West Pharmaceutical Services, Inc.
WSTNYSETrackedMarket Data VerifiedHealth CareHealth Care Supplies
- Coverage
- Coverage universe Identity published; no third-party ESG observation yet.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Last verified closeObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Down−USD 3.16 (−0.85%) Day change
The market is closed. This is the last verified closing quote, not an intraday price.
- Open
- USD 372.01
- Previous close
- USD 373.60
- Day high
- USD 372.14
- Day low
- USD 368.45
- Volume
- 433,964
- Market cap
- USD 26,069,997,568
View Chart Data
| Date and time | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| USD 254.99 | USD 262.90 | USD 254.76 | USD 261.52 | 591,900 | |
| USD 276.85 | USD 279.75 | USD 271.18 | USD 273.85 | 595,700 | |
| USD 278.39 | USD 281.80 | USD 274.88 | USD 277.14 | 441,100 | |
| USD 272.26 | USD 272.97 | USD 265.39 | USD 267.56 | 839,200 | |
| USD 274.54 | USD 277.75 | USD 273.90 | USD 276.87 | 356,600 | |
| USD 275.62 | USD 281.55 | USD 272.81 | USD 279.41 | 789,700 | |
| USD 230.90 | USD 237.67 | USD 228.83 | USD 237.50 | 1,203,500 | |
| USD 233.84 | USD 238.76 | USD 228.00 | USD 230.95 | 944,400 | |
| USD 243.90 | USD 248.46 | USD 243.89 | USD 248.26 | 813,700 | |
| USD 245.53 | USD 252.38 | USD 242.92 | USD 244.35 | 810,800 | |
| USD 238.85 | USD 241.40 | USD 236.12 | USD 237.03 | 1,186,900 | |
| USD 253.90 | USD 257.31 | USD 251.46 | USD 256.85 | 638,900 | |
| USD 278.00 | USD 281.25 | USD 273.88 | USD 274.72 | 947,800 | |
| USD 311.31 | USD 315.44 | USD 308.18 | USD 312.55 | 789,200 | |
| USD 308.17 | USD 316.60 | USD 304.80 | USD 316.13 | 743,500 | |
| USD 317.43 | USD 322.59 | USD 315.24 | USD 319.75 | 594,600 | |
| USD 335.72 | USD 345.99 | USD 335.72 | USD 340.41 | 872,400 | |
| USD 357.92 | USD 357.99 | USD 352.70 | USD 353.71 | 446,100 | |
| USD 329.24 | USD 336.72 | USD 325.27 | USD 331.25 | 1,605,500 | |
| USD 353.89 | USD 358.67 | USD 351.52 | USD 352.13 | 570,500 | |
| USD 353.75 | USD 354.78 | USD 348.22 | USD 348.48 | 383,700 | |
| USD 333.57 | USD 344.92 | USD 331.99 | USD 344.25 | 653,100 | |
| USD 370.93 | USD 376.06 | USD 368.20 | USD 375.87 | 876,900 | |
| USD 372.01 | USD 372.14 | USD 368.45 | USD 370.44 | 434,000 |
Company Profile & Business Model Overview
West Pharmaceutical Services, Inc. designs and produces containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
Sustainability Strengths & Catalysts (Pros)
- Critical injectables supplier
- Biologics secular tailwind
- High-quality recurring revenue
Material Risks & Governance Concerns (Cons)
- Premium valuation
- Customer concentration risk
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.
Audited Methodology
Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Core balance sheet and equity valuation metrics sourced from corporate filings.
Audited Financials
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is West Pharmaceutical Services, Inc. (WST)'s ESG rating and sustainability score?
Formal published scorecards from MSCI and Sustainalytics are under ongoing review for West Pharmaceutical Services, Inc. (WST). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Is West Pharmaceutical Services, Inc. considered an ESG leader or laggard in Health Care?
Independent benchmark status for West Pharmaceutical Services, Inc. is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.
What are the main ESG risks and controversies for West Pharmaceutical Services, Inc.?
Key material risks for West Pharmaceutical Services, Inc. include: Premium valuation; Customer concentration risk. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.